“…Since dopamine D2 receptor antagonists reverse the amphetamine-induced gating deficit, it has been proposed that enhanced dopamine neurotransmission results in disrupted gating (Stevens et al, 1996;Krause et al, 2003). Furthermore, enhanced catecholamine neurotransmission by amphetamine (Light et al, 1999) or cocaine (Adler et al, 2001) leads to impaired gating in humans. Interestingly, it has been demonstrated that amphetamine-or cocaine-induced gating deficit can be reversed not only with D2 antagonists, but with nicotine or nicotinic agonists as well (Stevens et al, 1995(Stevens et al, , 1999Adler et al, 2001), presumably interacting with inhibitory neuronal circuitry involved in gating, i.e., GABAergic interneurons in the hippocampus (Stevens et al, 1999;Freedman et al, 2000).…”